Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Ajanta pharma share price prediction, Ajanta Pharma top 10 products, Ajanta Pharma share price history, Ajanta Pharma NSE share price, Ajanta Pharma share price target 2030, Ajanta Pharma Share price target 2026, and much more. Furthermore, this page provides details on Ajanta Pharma‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Ajanta Pharma Company Information
| Industry | Pharmaceuticals Drugs Healthcare |
| Founded | 1973; 53 years ago |
| Headquarters | Mumbai, Maharashtra, India |
| Number of employees | 9,628 (2025) |
| Key people | Yogesh Agrawal (Managing Director) Rajesh Agrawal (Joint Managing Director) |
| Subsidiaries | Ajanta Pharma Inc., Kazakh Ajanta Pharma Ltd. |
Ajanta Pharma Share Price Target Overview
- Current Price – 3,010.60
- Open – 3,038.90
- High – 3,060.40
- Low – 2,980.00
- Mkt cap – 37.74KCr
- P/E ratio – 35.74
- 52-wk high – 3,314.90
- 52-wk low – 2,329.90
- Dividend – 1.39%
- Qtrly div amt – 10.49
Ajanta Pharma Share Price Chart
Ajanta Pharma Share Price Target Tomorrow (Prediction)
| Ajanta Pharma Share Price Target Years | Ajanta Pharma Share Price Target |
| 2026 | ₹3330 |
| 2027 | ₹3760 |
| 2028 | ₹4120 |
| 2029 | ₹4550 |
| 2030 | ₹4980 |
Ajanta Pharma Share Price Target 2026
The target for Ajanta Pharma’s share price in 2026 is projected to range between ₹3300 and ₹3330. As of the end of May 2026, Ajanta Pharma’s share price stood at ₹3,010.60. Compared to the previous year, Ajanta Pharma’s share price has witnessed an increase this year.
Ajanta Pharma Share Price Target 2027
The target for Ajanta Pharma’s share price in 2027 is projected to range between ₹3730 and ₹3760. On 29 May 2026, Ajanta Pharma Share price NSE is 3,010.60 INR. Compared to last year, no significant difference has been observed in the share price of Ajanta Pharma. The share price has increased by approximately 430-450 rupees.
Ajanta Pharma Share Price Target 2030
The target for Ajanta Pharma’s share price in 2030 is projected to range between ₹4950 and ₹4980. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Aspinwall & Company Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Ajanta Pharma Shareholding Pattern
| Promoter | 66.25% |
| FII | 8.26% |
| DII | 3.14% |
| Retails & Others | 7.12% |
| Mutual Funds | 15.22% |
Income Statement Of Ajanta Pharma
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
13.03B
|
13.54B
|
13.75B
|
14.22B
|
|
Cost of goods sold
|
2.76B
|
3.17B
|
2.86B
|
3.05B
|
|
Cost of revenue
|
2.76B
|
3.17B
|
2.86B
|
3.05B
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
3.03B
|
3.17B
|
3.31B
|
3.41B
|
|
Operating expense
|
6.92B
|
7.11B
|
7.50B
|
7.87B
|
|
Total operating expenses
|
9.67B
|
10.28B
|
10.36B
|
10.92B
|
|
Operating income
|
3.35B
|
3.26B
|
3.39B
|
3.30B
|
|
Other non operating income
|
169.50M
|
197.10M
|
164.20M
|
170.60M
|
|
EBT including unusual items
|
3.31B
|
3.41B
|
3.59B
|
3.47B
|
|
EBT excluding unusual items
|
3.31B
|
3.41B
|
3.59B
|
3.47B
|
|
Income tax expense
|
757.90M
|
806.20M
|
848.30M
|
804.10M
|
|
Effective tax rate
|
22.89%
|
23.66%
|
23.66%
|
23.17%
|
|
Other operating expenses
|
3.47B
|
3.51B
|
3.76B
|
4.01B
|
|
Net income
|
2.55B
|
2.60B
|
2.74B
|
2.67B
|
|
Net profit margin
|
19.60%
|
19.22%
|
19.91%
|
18.76%
|
|
Earnings per share
|
20.43
|
20.82
|
21.91
|
21.34
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-52.60M
|
-33.90M
|
-51.00M
|
-23.60M
|
|
Net interest expenses
|
-52.60M
|
-33.90M
|
-51.00M
|
-23.60M
|
|
Depreciation and amortization charges
|
412.90M
|
429.70M
|
435.10M
|
453.70M
|
|
EBITDA
|
3.66B
|
3.68B
|
3.70B
|
3.73B
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Shadowfax Technologies Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.